A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors
Clinical trial NCT04440735 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04440735
- Sponsor
- Kahr Medical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2025-09-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.